Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,673 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL.
Matsumoto N, Arase Y, Seko Y, Imai N, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Kobayashi M, Suzuki Y, Saito S, Suzuki F, Ikeda K, Kumada H, Aida K, Kobayashi T. Matsumoto N, et al. Among authors: suzuki f, suzuki y. Hepatol Res. 2012 Jun;42(6):558-63. doi: 10.1111/j.1872-034X.2011.00957.x. Epub 2012 Jan 11. Hepatol Res. 2012. PMID: 22236146
Long-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a prospective randomized controlled trial--CSWT with and without follow-up interferon-alpha therapy.
Akuta N, Suzuki F, Tsubota A, Arase Y, Suzuki Y, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H. Akuta N, et al. Among authors: suzuki f, suzuki y. Dig Dis Sci. 2002 Feb;47(2):405-14. doi: 10.1023/a:1013742727165. Dig Dis Sci. 2002. PMID: 11855559 Clinical Trial.
Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.
Akuta N, Suzuki F, Tsubota A, Suzuki Y, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: suzuki f, suzuki y. J Hepatol. 2002 Dec;37(6):831-6. doi: 10.1016/s0168-8278(02)00301-x. J Hepatol. 2002. PMID: 12445425
1,673 results